ELECTROCEUTICAL APPROACHES IN PARKINSON’S DISEASE MANAGEMENT: A REVIEW OF EFFICACY, SAFETY, AND LIMITATIONS
AbstractThe utilisation of electroceuticals in the treatment of Parkinson’s disease is the predominant topic of discussion in this review. Electroceuticals, which are frequently referred to as “bioelectronics medicine,” are the result of the utilisation of electrical impulses for the goal of therapeutic treatment. It has been investigated if electroceuticals could serve as an alternative or adjuvant to the conventional pharmaceutical therapies that are used in the treatment of Parkinson’s disease. The purpose of this review is to conduct a comprehensive analysis of the existing literature concerning a variety of electroceutical modalities. These modalities include deep brain stimulation (DBS), vagus nerve stimulation (VNS), and transcutaneous nerve stimulation (TNS), amongst others. An analysis is performed to determine the efficacy and safety of various methods, as well as to determine their limitations and potential future research areas. While the review comes to the conclusion that electroceuticals have the potential to be an advantageous addition to the arsenal of Parkinson’s disease treatments, it is important to note that further research is required to determine where they should be utilised in clinical settings.
Article Information
3
1296-1303
695 KB
538
English
IJPSR
M. M. Kachhi, S. R. Shinde and C. D. Bobade
School of Health Science and Technology, Department of Pharmaceutical Sciences, Dr. Vishwananth Karad MIT World Peace University, Kothrud, Pune, Maharashtra, India.
chandrashekhar.bobade@mitwpu.edu.in
21 August 2023
09 January 2024
04 April 2024
10.13040/IJPSR.0975-8232.15(5).1296-03
01 May 2024
Download